TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of participants with adverse events related to Cardiox FDS
Endpoint domain: Adverse events/effects
Primary endpoint: Time until first modification of antibiotic therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Remission Based on HDRS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Margins after RNSM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: MI (Myocardial Infarction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LV ejection fraction < 0.40
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical clearance of sBCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lipid oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cephalic presentation at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Ratio of CA Detected by the emergency dispatcher
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Belief update value
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reliability of d-xylose testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FVC% at PC20 MCh
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SVC% at PC20 MCh
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: regional air trapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Participation rate in the FLS program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time spent in moderate activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aquaporin 4 protein fragments in maternal blood plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S100B protein fragments in maternal blood plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aquaporin 4 protein fragments in cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S100B protein fragments in cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aquaporin 4 protein fragments in cord blood and placental samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in go no go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobilization of CD34 cells in the peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Little's Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Maximum Serum Drug Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Serum Drug Concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Drug Concentration-time Curve (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline diastolic blood pressure after 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline systolic blood pressure after 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stroke Impact Scale 3.0 Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Stroke Impact Scale-16 Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of treatment plan
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: EuroQol-5D 3L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of Patients Achieving Sufficient Tacrolimus Whole Blood Trough Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work of breath
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent Change in Time in Therapeutic Range (TTR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of CDR3 sizes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of Adhesions Number by 3 or More
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in diabetes self-care activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Detection of CIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Difference in pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Geometric Mean Concentration (GMC) of Anti-HBs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Job Retention Rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Duration of Sustained Employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: World Health Organization Quality of Life Assessment [WHOQOL-100]
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Completion of Academic Semesters
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Frequency and nature of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of respiratory adverse events of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: alveolar oxygen tension (PaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Kidney motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Expectancy Ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of BRCA1/2 mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Urine Samples Negative for Methamphetamine
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients who present death
Endpoint domain: Mortality/survival
Primary endpoint: Development of respiratory distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adherence to Guidelines for Body Mass Index Screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to Guidelines for Blood Pressure Screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to Guidelines for Blood Glucose/HbA1c Screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to Guidelines for LDL Cholesterol Screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to Guidelines for HDL Cholesterol Screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in BMI at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Bone Mineral Density (BMD) at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Percent (%) Lean Mass at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Percent (%) Fat Mass at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Plasma Phenylalanine at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pelvic floor muscle changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of infants with severe IVH, NEC, or death
Endpoint domain: Mortality/survival
Primary endpoint: Levels of Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: evolution of muscular pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of bleeding complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Postoperative peak of AST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hepatic Venous Pressure Measurement (HVPG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Index of Erectile Function (IIEF) 5
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma glucose profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Six-Month Participant Survival
Endpoint domain: Mortality/survival
Primary endpoint: Binocular distance-corrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC) of Ethinylestradiol (EE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of Ethinylestradiol (EE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC) of Norelgestromin (NGMN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of Norelgestromin (NGMN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects Who Withdrew Due to Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Subjects With a Serious Adverse Event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Mean Pain Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline of IBSSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Time Curve From Time 0 to Last Concentration (AUC0-last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Time Curve From Time 0 Extrapolated to Infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in AT inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: muscular activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Participants With Transient Neurological Symptoms on Day 1 Post-Operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-Operative Transient Neurological Symptoms Score on Day 1 Post-Operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Transient Neurological Symptoms on Post-Operative Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Transient Neurological Symptoms Score on Post-Operative Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Transient Neurological Symptoms on Post-Operative Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pharmacokinetics parameters of mosapride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Saphenous Vein Bypass Graft Vasodilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Wolf Motor Function Test (WMFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: revised Nottingham Sensory Assessment (rNSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Proportion of patients developing contrast-induced nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Assisting Hand Assessment (AHA) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for endotracheal intubation after failure of positive pressure ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Need for mechanical ventilation for neonates on nCPAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Progression of lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coagulopathy profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Nutrition profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changing MMP-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changing MMP-9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changing TIMP-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of Adverse Cardiac Events
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative reach (% usage in appropriate primary care consultations)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Biological factors contributing to DIPG/DMG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Perceived advantages of participation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived disadvantages of participation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Approval of participation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Disapproval of participation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Facilitators of participation
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Barriers to participation
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Tympanogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ear outcomes
Primary endpoint: Audiogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ear outcomes
Primary endpoint: Number Who Progressed
Endpoint domain: Mortality/survival
Primary endpoint: Probability of caries development in treated teeth
Endpoint domain: Mortality/survival
Primary endpoint: 7-day point prevalence of smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number Of Adverse Events related to the treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with cleared or almost cleared plaque psoriasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: UPDRS Part III OFF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Cannabis Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Blood glucose concentration change from baseline at 2 hours after drug administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the blood glucose concentration-time curve from time zero to time of last blood sample (AUC0-t,GLU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glycogen Synthase Phosphorylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Antibody titers of 1:40 or more for influenza A pandemic (H1N1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Ears With Otorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ear outcomes
Primary endpoint: area under the plasma concentration-time curve from time zero to infinity (AUC0 ∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the plasma concentration-time curve from time zero to the last observable concentration at time t (AUC0 t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postural assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pCR Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Program Logins Per Participant by Week
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: USE Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SUS Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall influence of a disease on daily life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: weekly mean proportion of cocaine-free days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-reported drinking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: craving for cocaine and alcohol
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: therapeutic effect of pulmonary surfactant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Total HIV DNA and integrated HIV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hush activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful induction of remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life in polycystic ovary syndrome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: quality of life's improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: improvement of treatment effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of their survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in Dermatology Life Quality Index (DLQI) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of Participants With 4-fold Rises in Levels of Pentacel™ Vaccine Antibody Titers Post-dose 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Titers of Antibodies to Pertussis, Diphtheria, Tetanus, Polyribosylribitol Phosphate and Poliovirus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Primary outcome
Endpoint domain: General outcomes
Primary endpoint: Accuracy (mean absolute relative difference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in perioral rhytids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Bronchodilation and Bronchoprotection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Correct application and maintenance of position of device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Nociception Coma Scale-Revised (NCS-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: Days alive without organ support
Endpoint domain: Mortality/survival
Primary endpoint: Decrease in average symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Maximum Bladder Capacity (MBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of participants with treatment related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Curve (AUC) Plasma Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of Enlite 3 Sensor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Methamphetamine-positive Urine Drug Screens
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma concentrations of canagliflozin and its major metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine concentrations of canagliflozin and its major metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician Severity Rating from ADIS for GAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penn State Worry Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depression Anxiety and Stress Scales, anxiety and stress subscales
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cerebral damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pharmacokinetics of intracellular CBV-TP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lunch Energy Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Disease Activity Score 28-CRP (DAS28-CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes